These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36531823)

  • 1. Lytic potential of a filamentous bacteriophage isolated from sewage water in Tehran on clinical carbapenem-resistant strains.
    Esmaeili-Fard-Barzegar K; Najar-Peerayeh S; Mazaheri Nezhad Fard R; Bakhshi B
    Iran J Microbiol; 2022 Oct; 14(5):705-711. PubMed ID: 36531823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.
    Ghaznavi-Rad E; Komijani M; Moradabadi A; Rezaei M; Shaykh-Baygloo N
    J Clin Lab Anal; 2022 Jul; 36(7):e24497. PubMed ID: 35708005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
    Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
    Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.
    Peng F; Mi Z; Huang Y; Yuan X; Niu W; Wang Y; Hua Y; Fan H; Bai C; Tong Y
    BMC Microbiol; 2014 Jul; 14():181. PubMed ID: 24996449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inventory building of phages against extensively drug-resistant Acinetobacter baumannii isolated from wounds of patients with severe burn and related characteristic analysis].
    Yang ZC; Deng LY; Gong YL; Yin SP; Jiang B; Huang GT; Peng YZ; Hu FQ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):517-22. PubMed ID: 27647066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant
    Samir S; El-Far A; Okasha H; Mahdy R; Samir F; Nasr S
    Saudi J Biol Sci; 2022 May; 29(5):3097-3106. PubMed ID: 35360502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and physical characterization of bacteriophage JHA against multidrug-resistant Acinetobacter baumannii.
    Ajmal H; Sharif Z; Zeshan B; Zahra N; Khan M
    Pak J Pharm Sci; 2022 Sep; 35(5):1327-1331. PubMed ID: 36451560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological, biological, and genomic characterization of Klebsiella pneumoniae phage vB_Kpn_ZC2.
    Fayez MS; Hakim TA; Zaki BM; Makky S; Abdelmoteleb M; Essam K; Safwat A; Abdelsattar AS; El-Shibiny A
    Virol J; 2023 May; 20(1):86. PubMed ID: 37138257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
    Fang Q; Zong Z
    mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.
    Yang H; Liang L; Lin S; Jia S
    BMC Microbiol; 2010 Apr; 10():131. PubMed ID: 20426877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.
    Leshkasheli L; Kutateladze M; Balarjishvili N; Bolkvadze D; Save J; Oechslin F; Que YA; Resch G
    J Glob Antimicrob Resist; 2019 Dec; 19():255-261. PubMed ID: 31100499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome characterization of the novel lytic phage vB_AbaAut_ChT04 and the antimicrobial activity of its lysin peptide against Acinetobacter baumannii isolates from different time periods.
    Leungtongkam U; Kitti T; Khongfak S; Thummeepak R; Tasanapak K; Wongwigkarn J; Khanthawong S; Belkhiri A; Ribeiro HG; Turner JS; Malik DJ; Sitthisak S
    Arch Virol; 2023 Sep; 168(9):238. PubMed ID: 37660314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
    Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Virulent T4-Like
    Peters DL; Davis CM; Harris G; Zhou H; Rather PN; Hrapovic S; Lam E; Dennis JJ; Chen W
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete genome sequence of the siphoviral bacteriophage Βϕ-R3177, which lyses an OXA-66-producing carbapenem-resistant Acinetobacter baumannii isolate.
    Jeon J; D'Souza R; Pinto N; Ryu CM; Park JH; Yong D; Lee K
    Arch Virol; 2015 Dec; 160(12):3157-60. PubMed ID: 26427378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant
    Teklemariam AD; Al-Hindi RR; Alharbi MG; Alotibi I; Azhari SA; Qadri I; Alamri T; Esmael A; Harakeh S
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
    Jeon J; Ryu CM; Lee JY; Park JH; Yong D; Lee K
    Appl Environ Microbiol; 2016 Jul; 82(14):4200-4208. PubMed ID: 27208124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.